Literature DB >> 17463047

Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE-19) cells: mechanism and regulation.

Veedamali S Subramanian1, Zainab M Mohammed, Andres Molina, Jonathan S Marchant, Nosratola D Vaziri, Hamid M Said.   

Abstract

Retinal abnormality and visual disturbances occur in thiamine-responsive megaloblastic anaemia (TRMA), an autosomal recessive disorder caused by mutations in the human thiamine transporter-1 (hTHTR-1). Human retinal pigment epithelial cells play a pivotal role in supplying thiamine to the highly metabolically active retina but nothing is known about the mechanism, regulation or biological processes involved in thiamine transport in these cells. To address these issues, we used human-derived retinal pigment epithelial ARPE-19 cells to characterize the thiamine uptake process. Thiamine uptake is energy- and temperature-dependent, pH-sensitive, Na+-independent, saturable at both the nanomolar (apparent Km, 30 +/- 5 nM) and the micromolar (apparent Km, 1.72 +/- 0.3 microM) concentration ranges, specific for thiamine and sensitive to sulfhydryl group inhibition. The diuretic amiloride caused a concentration-dependent inhibition in thiamine uptake, whereas the anti-trypanosomal drug, melarsoprol, failed to affect the uptake process. Both hTHTR-1 and hTHTR-2 are expressed in ARPE-19 cells as well as in native human retinal tissue with expression of the former being significantly higher than that of the latter. Uptake of thiamine was adaptively regulated by extracellular substrate level via transcriptionally mediated mechanisms that involve both hTHTR-1 and hTHTR-2; it was also regulated by an intracellular Ca2+-calmodulin-mediated pathway. Confocal imaging of living ARPE-19 cells expressing TRMA-associated hTHTR-1 mutants (D93H, S143F and G172D) showed various expression phenotypes. These results demonstrate for the first time the existence of a specialized and regulated uptake process for thiamine in a cellular model of human retinal pigment epithelia that involves hTHTR-1 and hTHTR-2. Further, clinically relevant mutations in hTHTR-1 lead to impaired cell surface expression or function of the transporter in retinal epithelial ARPE-19 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17463047      PMCID: PMC2075275          DOI: 10.1113/jphysiol.2007.128843

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  44 in total

1.  The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter.

Authors:  J C Fleming; E Tartaglini; M P Steinkamp; D F Schorderet; N Cohen; E J Neufeld
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

2.  Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.

Authors:  V Labay; T Raz; D Baron; H Mandel; H Williams; T Barrett; R Szargel; L McDonald; A Shalata; K Nosaka; S Gregory; N Cohen
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

3.  Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency.

Authors:  N Y Calingasan; S E Gandy; H Baker; K F Sheu; J D Smith; B T Lamb; J D Gearhart; J D Buxbaum; C Harper; D J Selkoe; D L Price; S S Sisodia; G E Gibson
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

4.  Thiamine deficiency in vivo produces fiber cell degeneration in mouse lenses.

Authors:  P H Frederikse; P Farnsworth; J S Zigler
Journal:  Biochem Biophys Res Commun       Date:  1999-05-19       Impact factor: 3.575

5.  Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts.

Authors:  A R Stagg; J C Fleming; M A Baker; M Sakamoto; N Cohen; E J Neufeld
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

6.  Thiamine deficiency alters APP but not presenilin-1 immunoreactivity in vulnerable brain regions.

Authors:  N Y Calingasan; S E Gandy; G E Gibson
Journal:  Neuroreport       Date:  1997-07-28       Impact factor: 1.837

7.  Glucose-induced activation of glucose uptake in cells from the inner and outer blood-retinal barrier.

Authors:  Julia V Busik; L Karl Olson; Maria B Grant; Douglas N Henry
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

8.  Compound missense mutations in the sodium/D-glucose cotransporter result in trafficking defects.

Authors:  M G Martín; M P Lostao; E Turk; J Lam; M Kreman; E M Wright
Journal:  Gastroenterology       Date:  1997-04       Impact factor: 22.682

9.  Blood and serum thiamin and thiamin phosphate esters concentrations in patients with alcohol dependence syndrome before and after thiamin treatment.

Authors:  C M Tallaksen; T Bøhmer; H Bell
Journal:  Alcohol Clin Exp Res       Date:  1992-04       Impact factor: 3.455

10.  Blood thiamine levels in outpatients with diabetes mellitus.

Authors:  N Saito; M Kimura; A Kuchiba; Y Itokawa
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  1987-12       Impact factor: 2.000

View more
  7 in total

1.  Tspan-1 interacts with the thiamine transporter-1 in human intestinal epithelial cells and modulates its stability.

Authors:  Svetlana M Nabokina; Sundar Rajan Senthilkumar; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

Review 2.  Intestinal absorption of water-soluble vitamins in health and disease.

Authors:  Hamid M Said
Journal:  Biochem J       Date:  2011-08-01       Impact factor: 3.857

3.  Relative contribution of THTR-1 and THTR-2 in thiamin uptake by pancreatic acinar cells: studies utilizing Slc19a2 and Slc19a3 knockout mouse models.

Authors:  Veedamali S Subramanian; Sandeep B Subramanya; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-22       Impact factor: 4.052

4.  Pancreatic beta cells and islets take up thiamin by a regulated carrier-mediated process: studies using mice and human pancreatic preparations.

Authors:  Lisa Mee; Svetlana M Nabokina; V Thillai Sekar; Veedamali S Subramanian; Kathrin Maedler; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-05-07       Impact factor: 4.052

Review 5.  Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors.

Authors:  Rongbao Zhao; I David Goldman
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

6.  The role of insulin-like growth factor-I in the physiopathology of hearing.

Authors:  Silvia Murillo-Cuesta; Lourdes Rodríguez-de la Rosa; Rafael Cediel; Luis Lassaletta; Isabel Varela-Nieto
Journal:  Front Mol Neurosci       Date:  2011-07-25       Impact factor: 5.639

7.  Thiamine transporter 2 is involved in high glucose-induced damage and altered thiamine availability in cell models of diabetic retinopathy.

Authors:  Elena Beltramo; Aurora Mazzeo; Tatiana Lopatina; Marina Trento; Massimo Porta
Journal:  Diab Vasc Dis Res       Date:  2019-11-14       Impact factor: 3.291

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.